Product How it works Pricing Blog FAQ About Contact
Albemarle

Albemarle (NYSE: ALB) net income

Albemarle reported a net loss of $510.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $1,179m. Earnings per share were −$5.76.

Net income, in millions of US dollars643.7201654.92017693.62018533.22019375.82020123.720212,69020221,5732023-1,1792024-510.62025

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025−$510.6m—−9.9%−$5.76
2024−$1,179m−175.0%−21.9%−$11.20
2023$1,573m−41.5%16.4%$13.41
2022$2,690m+2,075.0%36.7%$22.97
2021$123.7m−67.1%3.7%$1.07
2020$375.8m−29.5%12.0%$3.53
2019$533.2m−23.1%14.9%$5.03
2018$693.6m+1,164.5%20.6%$6.40
2017$54.9m−91.5%1.8%$0.49
2016$643.7m—24.0%$5.73

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Questions about the net income of Albemarle

How much did Albemarle earn in fiscal 2025?
Albemarle reported a net loss of $510.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $1,179m.
What are the earnings per share of Albemarle?
They were −$5.76 in fiscal 2025, compared with −$11.20 in fiscal 2024.
What was the most profitable year for Albemarle?
Of its last 10 fiscal years, fiscal 2022, with $2,690m.
Where do the figures for Albemarle come from?
From the annual report (Form 10-K) that Albemarle files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Albemarle files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Albemarle: the Albemarle page · annual accounts · revenue · dividends paid · insider transactions.

Dividend per share of Albemarle by fiscal year, with the filing behind every figure: Albemarle dividend history.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.